To elucidate the mechanisms underlying the therapeutic effects of nor@MSC‐EVs in a psoriasis mouse model, bulk RNA sequencing was conducted on skin lesions from psoriasis mice treated with PBS, nor@MSC‐EVs, and anti‐IL17A (Figure 6A). Here, IL17A is linked to psoriasis.